Skip to content

A clinical study on application of ciprofol and propfol in general anesthesia of painless abortion

A clinical study on application of ciprofol and propfol in general anesthesia of painless abortion

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055113
Enrollment
Unknown
Registered
2022-01-01
Start date
2022-01-07
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Ciprofol group:Intravenous bolus injection of cyclopofol 0.4 mg/kg
Propofol group:Propofol injection 2.0mg/kg

Sponsors

Yunnan Province Maternal and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-35 years; 2. American Anesthesiologist Classification (ASA) I-II; 3. Outpatient patients undergoing elective general anesthesia induced abortion; 4. Pregnancy time is 6 to 10 weeks; 5. Body mass index (BMI) 18-30kg/m^2; 6. Vital signs: respiratory rate >=10 and =95% when breathing air; systolic blood pressure (SBP) >=90mmHg and =60mmHg and =55 and <=100 beats/min; 7. Be able to understand the research process and method, and voluntarily participate in this research.

Exclusion criteria

Exclusion criteria: 1. Those with contraindications to intravenous general anesthesia or those who have had a history of anesthesia accident in the past; 2. Known or suspected to be allergic or contraindicated to propofol injection, cyclopofol injection and other excipients; 3. Combined with craniocerebral loss, intracranial hypertension, stroke, unstable angina, myocardial infarction; 4. Respiratory insufficiency, obstructive pulmonary disease, difficult airway or judged to be difficult for endotracheal intubation (modified Markov score grade III or IV); 5. Uncontrolled diabetes or high blood pressure; 6. Severe liver dysfunction or severe renal insufficiency; 7. History of alcoholism or drug dependence; 8. Abuse or long-term use of narcotic, sedative, and analgesic drugs; 9. Those who have a history of mental illness in the past; 10. Those who have participated in any drug clinical trials within 1 month before screening; 11. Subjects who are considered by the investigator to have any other factors that are not suitable for participating in this trial.

Design outcomes

Primary

MeasureTime frame
Success rate of anesthesia induction;

Secondary

MeasureTime frame
Effects on respiratory and circulatory systems;Time of anesthesia induction;Recovery time after anesthesia;Time required to leave the hospital after anesthesia;Frequency and dose of ciprofol and propofol injection;

Countries

China

Contacts

Public ContactCheng Shangchao

Yunnan Province Maternal and Child Health Care Hospital

2061531472@qq.com+86 13378848704

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026